Baboon study
Ended Purchase Order Awarded Last action
- Contract number
- 75D30122P15395
- Awardee
-
Texas Biomedical Research Institute UEI J4EYPCJDQ1H6
- Awarding agency
-
CDC Pittsburgh
Centers for Disease Control and Prevention, Department of Health and Human Services
- Obligated
- $235,142
Award facts
- Opportunity
-
- 75D30122Q75709 Solicitation number
- Contract value 99% obligated
- $237,920.72 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- PSC
- 8820 Live Animals, Not Raised For Food
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- San Antonio, TX 78227, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | -$2,779 | |
| Other Administrative Action | $0 | |
| Original award | $237,921 |
About this award
The Centers for Disease Control and Prevention (CDC) Pittsburgh awarded a $237,920.72 firm fixed price purchase order to Texas Biomedical Research Institute (also doing business as Southwest Foundation for Biomedical Research) for a baboon study. The contract was awarded on September 15, 2022, with an ultimate completion date of September 14, 2023, and performance will be conducted at the awardee's facility in San Antonio, Texas. No set-aside designation was applied to this award.
Texas Biomedical Research Institute is a non-profit research organization specializing in infectious disease research and operating the Southwest National Primate Research Center. As a critical federal partner in biomedical research, the institute leverages its expertise in non-human primate models to support CDC and other federal agencies' research initiatives. This baboon study aligns with the institute's core competencies in providing advanced animal model services for infectious disease research, vaccine development, and medical countermeasures—work that supports federal preparedness and public health objectives.
Quick answers
Who was awarded contract 75D30122P15395?
75D30122P15395 was awarded to Texas Biomedical Research Institute by CDC Pittsburgh (Centers for Disease Control and Prevention) on September 15, 2022.
How much is contract 75D30122P15395 worth?
The government has obligated $235,142 on 75D30122P15395. Its current value, with exercised options, is $237,921.
Was contract 75D30122P15395 competed?
The extent of competition for 75D30122P15395 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award